Cantabio Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This Disclosure rating covers 17 UN SDGs including: 'Clean Water & Sanitation', 'Industry, Innovation & Infrastructure' and 'Partnerships for the Goals'. Alternative corporations in the scoring industry group for Cantabio Pharmaceuticals Inc are displayed below. The report of Cantabio Pharmaceuticals Inc is assembled by All Street Sevva using leading machine learning.
Cantabio Pharmaceuticals Inc in the Business Support Services industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Calian Group Ltd | 8.0 | High |
| 1 | CARE Ratings Ltd | 8.0 | High |
| ... | ... | ... | |
| 607 | Pony Testing International Group Co Ltd | 0.4 | Low |
| 607 | Verra Mobility Corp | 0.4 | Low |
| 617 | Cantabio Pharmaceuticals Inc | 0.0 | Low |
| 617 | CSS Holdings Ltd | 0.0 | Low |
| 617 | CTPartners Executive Search Inc | 0.0 | Low |
| 617 | iBosses Corporation Ltd | 0.0 | Low |
| 617 | iMarketKorea Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cantabio Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Cantabio Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cantabio Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cantabio Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Cantabio Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cantabio Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cantabio Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Cantabio Pharmaceuticals, Inc., a preclinical stage biotechnology company, focuses on the research, development, and commercialization of novel therapies for Parkinson's disease (PD), Alzheimer's disease (AD), and other related diseases. Its lead programs include CB101, a DJ-1 targeting small molecule pharmacological chaperone for use in the treatment of PD; CB201, a CNS penetrant engineered DJ-1 protein for use in the treatment of PD; CB301, a Tau protein targeting small molecule pharmacological chaperone for use in the treatment of AD; and CB401, an Aß targeting small molecule pharmacological chaperone for use in the treatment of AD. The company has a collaboration agreement with Luxembourg Institute of Health to research the therapeutic targeting of the DJ-1 - protein to treat immune associated diseases. The company was founded in 2009 and is based in Palo Alto, California.